what announcement next, page-11

"Of-course the Spin off will devalue the value of ACL, the SP will take a massive hit. Oncology will need lots of funding so it could take most of what Fonda has generated with it- Plus there will be an IPO"

I disagree with you Neo. I also think you will be far better "selling out" after the split.

The oncology company will probably take the bulk of acl's cash, so maybe $20m. A further $10m may also be raised. There's then the options, which could bring in another $5m.

So there's around $35m, which is more than enough to get the phase 3 done and dusted.

Assuming that HyACT proves to be successful (which all evidence to date suggests it will). Then we have a multi product proven technology. Any further trials (if not sponser funded) will easily attract partnerships. Of course success would also mean that income will start flow in within a few years too!

So with all that potential and enough cash to finish the trial, I can imagine the market giving oncology a valuation of at least $200m (some months after the split). They will be ripe for takeover potential too!

all imho, cheers

ps. I think you are being too negative. didn't you say sell at around 34c a few weeks back?